Fenofibrate inhibits atrial metabolic remodelling in atrial fibrillation through PPAR-α/sirtuin 1/PGC-1α pathway

British Journal of Pharmacology
Guangzhong LiuWeimin Li

Abstract

Atrial metabolic remodelling is critical for the process of atrial fibrillation (AF). The PPAR-α/sirtuin 1 /PPAR co-activator α (PGC-1α) pathway plays an important role in maintaining energy metabolism. However, the effect of the PPAR-α agonist fenofibrate on AF is unclear. Therefore, the aim of this study was to determine the effect of fenofibrate on atrial metabolic remodelling in AF and explore its possible mechanisms of action. The expression of metabolic proteins was examined in the left atria of AF patients. Thirty-two rabbits were divided into sham, AF (pacing with 600 beats·min(-1) for 1 week), fenofibrate treated (pretreated with fenofibrate before pacing) and fenofibrate alone treated (for 2 weeks) groups. HL-1 cells were subjected to rapid pacing in the presence or absence of fenofibrate, the PPAR-α antagonist GW6471 or sirtuin 1-specific inhibitor EX527. Metabolic factors, circulating biochemical metabolites, atrial electrophysiology, adenine nucleotide levels and accumulation of glycogen and lipid droplets were assessed. The PPAR-α/sirtuin 1/PGC-1α pathway was significantly inhibited in AF patients and in the rabbit/HL-1 cell models, resulting in a reduction of key downstream metabolic factors; this effect was sign...Continue Reading

References

Mar 11, 2003·American Journal of Physiology. Heart and Circulatory Physiology·Yong-Mei ChaMargaret M Redfield
Feb 9, 2005·Journal of Molecular and Cellular Cardiology·Zhenjiang YangKatherine T Murray
Mar 29, 2005·Molecular and Cellular Biochemistry·Evelin SeppetEnn K Seppet
Nov 18, 2006·Circulation Research·Bianca J J M BrundelStanley Nattel
Dec 15, 2006·Nature·Leonard Guarente
Jan 2, 2007·The Journal of Biological Chemistry·Masaya TannoYoshiyuki Horio
Jan 5, 2008·Journal of the American College of Cardiology·Grace Casaclang-VerzosaTeresa S M Tsang
Feb 2, 2008·Journal of the American College of Cardiology·Manuel MayrA John Camm
May 9, 2008·Journal of Molecular and Cellular Cardiology·Jose A Madrazo, Daniel P Kelly
Dec 25, 2008·PloS One·Tsutomu SasakiHeidi Scrable
Jul 8, 2010·The Journal of Gene Medicine·Carol KilkennyUNKNOWN NC3Rs Reporting Guidelines Working Group
Jul 17, 2010·The Journal of Physiology·UNKNOWN NC3Rs Reporting Guidelines Working Group
Jul 24, 2010·British Journal of Pharmacology·Carol KilkennyUNKNOWN NC3Rs Reporting Guidelines Working Group
Oct 12, 2012·Journal of Advanced Pharmaceutical Technology & Research·G S SuggaR Khanam
Dec 12, 2012·PloS One·Constantin YanicostasNadia Soussi-Yanicostas
Nov 16, 2013·Nucleic Acids Research·Adam J PawsonUNKNOWN NC-IUPHAR
Dec 18, 2013·Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology·Yixi LiuWeimin Li
Jan 7, 2014·Trends in Endocrinology and Metabolism : TEM·Hung-Chun Chang, Leonard Guarente
Feb 6, 2014·American Journal of Physiology. Endocrinology and Metabolism·Jessica A BonzoFrank J Gonzalez
Feb 21, 2014·Circulation Journal : Official Journal of the Japanese Circulation Society·Tao TuQiming Liu

❮ Previous
Next ❯

Citations

Jan 21, 2017·International Journal of Obesity : Journal of the International Association for the Study of Obesity·P BaskaranB Thyagarajan
Jan 1, 2018·Fundamental & Clinical Pharmacology·Ishfaq A BukhariSaeed A Sheikh
Oct 27, 2017·Circulation Journal : Official Journal of the Japanese Circulation Society·Masahide HaradaStanley Nattel
Mar 8, 2019·Combinatorial Chemistry & High Throughput Screening·Mustafa Begenc Tascanov
Mar 11, 2019·Naunyn-Schmiedeberg's Archives of Pharmacology·Guang-Zhong LiuYue Li
Jun 5, 2019·Journal of Cardiovascular Pharmacology and Therapeutics·Hongyan ZhaoWeimin Li
Jun 17, 2020·Frontiers in Physiology·Koen T ScholmanBastiaan J Boukens
Mar 3, 2021·Scandinavian Cardiovascular Journal : SCJ·Are A KalstadIngebjørg Seljeflot
Mar 2, 2021·The Journal of International Medical Research·Zhongping NingYingbiao Wu
Jun 3, 2021·Journal of Clinical Medicine·Paweł Muszyński, Tomasz A Bonda
Aug 24, 2021·Cardiology Research and Practice·Xi ZhuZhongping Ning
Jul 27, 2020·European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery·Joseph V MoxonJonathan Golledge
May 1, 2018·International Journal of Cardiology·Chang CuiMinglong Chen

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atrial Filbrillation

Atrial fibrillation refers to the abnormal heart rhythm characterized by rapid and irregular beating of the atria. Here is the latest research.

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Cardiac Remodeling

Cardiac remodeling in response to a myocardial infarction is characterized by progressive ventricular dilatation, cardiac hypertrophy, fibrosis, and deterioration of cardiac performance. Discover the latest research on Cardiac Remodeling here.